Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
REGN7257 for Severe Aplastic Anemia
Recruiting1 awardPhase 1 & 2
Cleveland, Ohio
This trial is testing a new drug called REGN7257 for patients with severe aplastic anemia who haven't responded to other treatments. The drug aims to help the bone marrow produce more blood cells and reduce the need for transfusions. The study will check if the drug is safe and how well it works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service